Navigation Links
Circassia Acquires North American and Japanese Rights to Dopexamine
Date:10/8/2008

examine is not approved for use currently in the US, Canada or Japan.

"ToleroCare has great potential to dramatically improve patients' recovery following major surgery, as well as to significantly reduce costs by shortening the time spent in hospital. With approximately 825,000 high-risk surgical procedures carried out each year in the US, and the high cost associated with hospital stays, ToleroCare is targeting a major market opportunity," said Steve Harris, Circassia's CEO. "Dopexamine provides Circassia with a further phase II clinical-stage development programme that fits well with our outsourced business model. By establishing a commercial-scale supply chain for dopexamine, we are well positioned to rapidly progress ToleroCare to market."

About Circassia

Circassia is a specialty biopharmaceutical company focused on the fields of allergy and critical care. The company has a highly experienced management team with a proven track record in product development and commercialization, and having successfully completed two fundraising rounds is backed by a syndicate of world-class venture capital and institutional investors, which includes Imperial Innovations, Lansdowne Partners, Goldman Sachs and Invesco Perpetual.

Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization technology, ToleroMune(R). The company is also developing its ToleroTrans(R) organ anti-rejection technology, which uses a similar approach to down-regulate immune responses in transplant patients. Circassia has a number of ongoing development programmes, with the most advanced against cat-dander allergy in phase II clinical testing.
For more information please visit http://www.circassia.co.uk.

Contacts

Steve Harris Rob Budge

CEO RJB Communications

Circassia Tel: +44(0)1865-7609
'/>"/>

SOURCE Circassia Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding
2. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
3. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
4. Neogen Acquires Kane Enterprises
5. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
6. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
7. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
8. NSF International Acquires David Begg Associates
9. United BioSource Acquires Caro Research, Leader in Simulation Modeling
10. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
11. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Fla. , Sept. 2, 2014  Technology Applications ... announced that its wholly-owned subsidiary Renuell Int,l, Inc. has ... Aeronautics and Space Administration ("NASA") at the Johnson Space ... See photos: tapplic.com/houstonphotos/ ... "We are very pleased to announce our latest, exclusive ...
(Date:9/2/2014)... Philadelphia, PA (PRWEB) September 02, 2014 ... pioneered a new highly efficient, cost effective approach ... U.S. Patent No. 8,820,265 by the U.S. Patent ... proprietary to Opertech. , “Opertech’s taste ... is the first automated high throughput system for ...
(Date:9/2/2014)... Sept. 2, 2014  Xencor, Inc. (NASDAQ: ... engineered monoclonal antibodies for the treatment of autoimmune ... announced the appointment of Debra Zack , ... appointment of Lloyd Rowland , senior vice ... "Debra,s expertise in biologics clinical development ...
(Date:9/2/2014)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... targeting specific pathogens that cause serious infections and ... preclinical toxicology study of SYN-004. Per U.S. Food ... was required to move the Company,s lead anti-infective, ... effects of Clostridium difficile (C. difficile), ...
Breaking Biology Technology:Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Opertech Bio Receives U.S. Patent for High-Throughput Taste Evaluation Technology 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 2Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 3Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 4Synthetic Biologics to Initiate Clinical Trials of SYN-004 in 4Q 2014 to Prevent Potentially Deadly C. difficile Infections 5
... 29 Abt Associates has been,ranked 19th in the ... 50 U.S. Research firms. The listing is based on ... research revenue for,calendar 2007 was $55.1 million. Total company ... $225 million., Abt Associates market research activities are ...
... Purification Testing, Standards and Procedures, SHAANXI, China, ... (OTC Bulletin Board: HFGB), a leading,developer and producer ... the,production of pharmaceuticals, nutraceuticals and food production, today,released ... application for COS,approval for the delivery of Diosmin ...
... Volcano Corporation,(Nasdaq: VOLC ), a leading ... (FM) and Optical Coherence,Tomography (OCT) products designed to ... vascular disease, today announced that it will,report its ... six months of,fiscal 2008 on Tuesday, August 5., ...
Cached Biology Technology:Abt Associates Ranked One of Top 20 U.S. Market Research Firms 2Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 2Huifeng Bio-Pharmaceutical (HFGB) Provides Update on COS Application Status 3Volcano Corporation Schedules Second Quarter Conference Call, Webcast 2
(Date:9/2/2014)... integrity? Tell the truth; everyone has a tipping point. We ... lie if the benefit is great enough. Now, scientists have ... that decision. , The result was published online this ... prefer to be honest, even if lying is beneficial," said ... at the Virginia Tech Carilion Research Institute , where ...
(Date:9/2/2014)... in Taiyuan, China, have substantially improved the health of ... reduction in costs associated with loss of life and ... the Columbia Center for Children,s Environmental Health (CCCEH) at ... University, the Center of Diseases Control and Prevention of ... Health. , The study is the first to document ...
(Date:9/2/2014)... When you accidentally touch a hot oven, you rapidly ... neural circuits involved in sensing and responding to such ... players. , Duke researchers have made a surprising discovery ... pain in worms, and have built a structural model ... Nature Communications , may help direct new strategies ...
Breaking Biology News(10 mins):Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 2Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 3Scientists find possible neurobiological basis for tradeoff between honesty, self-interest 4Clean air halves health costs in Chinese city 2Surprising new role for calcium in sensing pain 2Surprising new role for calcium in sensing pain 3
... University of the Negev researcher Dr. Taleb Mokari, a ... and Technology, has been awarded a prestigious Krill Prize ... the Prize for his work on developing novel nanostructures ... a senior lecturer in BGU,s Department of Chemistry. His ...
... of time families spend eating meals together has been ... teens, with families who eat together regularly reporting declines ... their children. Now, a new study that looks at ... family interactions during mealtime affected the children,s health. ...
... percent of dairy herds and causes an estimated annual ... A contagious, chronic and usually fatal bacterial infection of ... milk production, causes weight loss in cows, and contributes ... Institute for Mathematical and Biological Synthesis (NIMBioS) is now ...
Cached Biology News:Family mealtimes play a role in health of children with asthma 2Wasting disease in cattle focus of workshop 2